Company · CIK 0001737287
Allogene Therapeutics, Inc.
ALLOSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$1.46+$0.06 (+4.29%)
ALLO · Last trade
- Prev close
- $1.40
- Range (29d)
- $1.40 – $1.78
On the record
Recent filings
- SCHEDULE 13D/AALLOAllogene Therapeutics, Inc.0001999371-26-021654 · 15.7 KBSEC(opens sec.gov)
- 8-KALLOCurrent report0001193125-26-379423 · 131.3 KBSEC(opens sec.gov)
- 144ALLOAllogene Therapeutics, Inc.0001737287-26-000023 · 4.3 KBSEC(opens sec.gov)
- SCHEDULE 13G/AALLOAllogene Therapeutics, Inc.0001231919-26-000912 · 30.8 KBSEC(opens sec.gov)
- 10-QALLOQuarterly update0001628280-26-056213 · 8.4 MBSEC(opens sec.gov)
- 8-KALLOCurrent report0001628280-26-056198 · 213.1 KBSEC(opens sec.gov)
- SCHEDULE 13G/AALLOAllogene Therapeutics, Inc.0001296549-26-000008 · 38.6 KBSEC(opens sec.gov)
- SCHEDULE 13GALLOAllogene Therapeutics, Inc.0000093751-26-000405 · 8.0 KBSEC(opens sec.gov)
- 8-KALLOCurrent report0001628280-26-044618 · 221.2 KBSEC(opens sec.gov)
- 8-KALLOCurrent report0001193125-26-245484 · 140.2 KBSEC(opens sec.gov)
Insiders
- Amado RafaelEVP of R&D
- Barrett Elizabeth A.Director
- Belldegrun ArieDirector
- Beneski Benjamin MachinasSVP, Chief Technical Officer
- Bhavnagri VeerGeneral Counsel
- BONDERMAN DAVIDDirector, 10% Owner
- Chang David DDirector, President and CEO
- CHEN YINLIN JACKSVP, Finance
- COULTER JAMES G10% Owner
- DEYOUNG JOHN A.Director
Tickers
Addresses
business
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080
mailing
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies